List of Excipients in API raltegravir
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing raltegravir
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | BUTYLATED HYDROXYTOLUENE | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | CELLULOSE, MICROCRYSTALLINE | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | FERRIC OXIDE RED | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | FERROSOFERRIC OXIDE | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | HYPROMELLOSE | 2031-04-21 |
| Merck Sharp & Dohme LLC | ISENTRESS | raltegravir | 0006-0227 | LACTOSE MONOHYDRATE | 2031-04-21 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for raltegravir
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
raltegravir drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
raltegravir drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Dispensing Solutions Inc | raltegravir | 66336-214 |
| NuCare PharmaceuticalsInc | raltegravir | 68071-2113 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
raltegravir drug variants containing BUTYLATED HYDROXYTOLUENE
raltegravir drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
raltegravir drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Dispensing Solutions Inc | raltegravir | 66336-214 |
| NuCare PharmaceuticalsInc | raltegravir | 68071-2113 |
| >Company | >Ingredient | >NDC |
raltegravir drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
raltegravir drug variants containing CELLULOSE, MICROCRYSTALLINE
raltegravir drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
raltegravir drug variants containing FERRIC OXIDE RED
raltegravir drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
raltegravir drug variants containing FERROSOFERRIC OXIDE
raltegravir drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
raltegravir drug variants containing HYPROMELLOSE
raltegravir drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | raltegravir | 54868-0117 |
| Dispensing Solutions Inc | raltegravir | 66336-214 |
| NuCare PharmaceuticalsInc | raltegravir | 68071-2113 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
raltegravir drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | raltegravir | 54868-0117 |
| Dispensing Solutions Inc | raltegravir | 66336-214 |
| NuCare PharmaceuticalsInc | raltegravir | 68071-2113 |
| >Company | >Ingredient | >NDC |
raltegravir drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
raltegravir drug variants containing LACTOSE MONOHYDRATE
raltegravir drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
raltegravir drug variants containing MAGNESIUM STEARATE
raltegravir drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
raltegravir drug variants containing POLOXAMER 407
raltegravir drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
raltegravir drug variants containing POLYETHYLENE GLYCOL 3350
raltegravir drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
raltegravir drug variants containing POLYVINYL ALCOHOL
raltegravir drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
raltegravir drug variants containing SODIUM STEARYL FUMARATE
raltegravir drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
raltegravir drug variants containing TALC
raltegravir drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
raltegravir drug variants containing TITANIUM DIOXIDE
raltegravir drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
